Registry for patients with bone and soft tissue tumors
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
This study is creating a secure online registry to collect health information from people with bone and soft tissue tumors to help improve treatment and understand their condition better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT02677961 on ClinicalTrials.gov |
What this trial studies
This study aims to create a secure electronic health record (EHR)-based registry to collect clinical and research data on individuals diagnosed with bone and soft tissue tumors. It focuses on identifying clinical and molecular features that may influence prognosis and treatment responses. The registry will also standardize the collection of biospecimens for biomarker analysis and promote collaboration between institutions for future research. Patients will complete quality of life questionnaires and may provide blood samples over a two-year period.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed or presumed to have bone or soft tissue tumors as classified by the WHO.
Not a fit: Patients who are prisoners will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of bone and soft tissue tumors, leading to improved treatment strategies and patient outcomes.
How similar studies have performed: Other studies have successfully utilized similar registry approaches to enhance cancer research, particularly for rare diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must have a diagnosis or presumed diagnosis of bone or soft tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.) * Patient, or his/her designated power of attorney, must be able to understand and approve of the consent to participate. Exclusion Criteria: * Prisoners are excluded from participation in the Registry.
Where this trial is running
Columbus, Ohio
- Ohio State University — Columbus, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: David A Liebner, MD — Ohio State University
- Study coordinator: Erin Fetzer
- Email: erin.fetzer@osumc.edu
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.